400 related articles for article (PubMed ID: 22529099)
1. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes.
Massonnet B; Normand S; Moschitz R; Delwail A; Favot L; Garcia M; Bourmeyster N; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):112-20. PubMed ID: 19825520
[TBL] [Abstract][Full Text] [Related]
3. Mevalonate pathway: a review of clinical and therapeutical implications.
Buhaescu I; Izzedine H
Clin Biochem; 2007 Jun; 40(9-10):575-84. PubMed ID: 17467679
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate Pathway and Human Cancers.
Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
6. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
7. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
8. Novel prospects of statins as therapeutic agents in cancer.
Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
Karlic H; Thaler R; Gerner C; Grunt T; Proestling K; Haider F; Varga F
Cancer Genet; 2015 May; 208(5):241-52. PubMed ID: 25978957
[TBL] [Abstract][Full Text] [Related]
10. Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
Sarrabayrouse G; Pich C; Teiti I; Tilkin-Mariame AF
Int J Cancer; 2017 Feb; 140(4):747-755. PubMed ID: 27616679
[TBL] [Abstract][Full Text] [Related]
11. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
12. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
13. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
[TBL] [Abstract][Full Text] [Related]
14. Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapy.
Konstantinopoulos PA; Papavassiliou AG
Trends Pharmacol Sci; 2007 Jan; 28(1):6-13. PubMed ID: 17150261
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Mevalonate Pathway in Cancer.
Juarez D; Fruman DA
Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
[TBL] [Abstract][Full Text] [Related]
16. Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link.
Tricarico PM; Crovella S; Celsi F
Int J Mol Sci; 2015 Jul; 16(7):16067-84. PubMed ID: 26184189
[TBL] [Abstract][Full Text] [Related]
17. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer therapy: targeting the mevalonate pathway.
Swanson KM; Hohl RJ
Curr Cancer Drug Targets; 2006 Feb; 6(1):15-37. PubMed ID: 16475974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
